Published Date: 06 Nov 2025
People diagnosed with advanced breast cancer in 2025 can expect to live for an extra six or seven months, compared to the average survival time for patients diagnosed in 2011, according to a major study of patient data in ...
Read Full News1.
Novel biomarker has potential for predicting and treating skin cancer metastasis
2.
HER2 ADC Shows Promise in Recurrent Endometrial Cancer
3.
Atezolizumab Consolidation Impresses in High-Risk DLBCL
4.
A hint regarding aspirin, the connection to colon cancer, the approval of the new Lutathera, artificial intelligence, and electronic records.
5.
Study: Elinzanetant cuts vasomotor symptoms in women with breast cancer on endocrine therapy
1.
Unveiling the Hidden Mechanisms of Hemolytic Reactions
2.
Battling Blood Cancers: Advances in HIV-Related Hematologic Malignancies in the ART Era
3.
Abemaciclib in Combination with Therapies for Patients with Metastatic Breast Cancer
4.
Future of Chemotherapy: New Advances, Treatments & Survival Rates Transforming Cancer Care
5.
A New Hope: How Procarbazine is Revolutionizing Cancer Treatment
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
International Lung Cancer Congress®
1.
Navigating the Complexities of Ph Negative ALL - Part XIV
2.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
3.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion IV
4.
Daratumumab, Lenalidomide, and Dexamethasone (DRd) Versus Lenalidomide and Dexamethasone (Rd) in MRD Negativity
5.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part IV
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation